Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Vania E. Kenanova"'
Autor:
Anna M. Wu, John E. Shively, Andrew A. Raubitschek, Jeffrey Y.C. Wong, Lawrence E. Williams, Sanjiv S. Gambhir, Michael F. Press, Lin Li, Paul J. Yazaki, Desiree Crow, Anne-Line Anderson, Gobalakrishnan Sundaresan, Vania E. Kenanova, Tove Olafsen
Supporting Information from Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments for In vivo Imaging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba7a2aa319b50dbb8084936e7d10390
https://doi.org/10.1158/0008-5472.22364756.v1
https://doi.org/10.1158/0008-5472.22364756.v1
Autor:
Ingvild Sørum Leikfoss, Inger Sandlie, Derry C. Roopenian, Vania E. Kenanova, Jan Terje Andersen, Tove Olafsen, Stian Foss, Anna M. Wu
Publikováno v:
The Journal of Biological Chemistry
Background: FcRn regulates the serum half-life of IgG. Results: Fc engineering of scFv-Fc affects binding to mFcRn and hFcRn differently, which reflects blood clearance in WT and transgenic mice. Conclusion: Modulating FcRn binding to scFv-Fc reveals
Autor:
Michael M. Weinstein, Chika Nobumori, Koon-Pong Wong, Sung-Cheng Huang, Ira J. Goldberg, Tove Olafsen, Constance V. Voss, Vania E. Kenanova, André Bensadoun, Yiping Tu, Glen Young, Loren G. Fong, Anna M. Wu, Richard H. Barnes, Anne P. Beigneux, Stephen G. Young, Brandon S.J. Davies
Publikováno v:
Journal of Biological Chemistry. 285:39239-39248
Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1), a GPI-anchored endothelial cell protein, binds lipoprotein lipase (LPL) and transports it into the lumen of capillaries where it hydrolyzes triglycerides in l
Autor:
Felix B. Salazar, John M. Timmerman, Pat Clarke, Tove Olafsen, David J. Betting, Andrew Raubitschek, Anna M. Wu, Jonathan W. Said, Vania E. Kenanova
Publikováno v:
Journal of Nuclear Medicine. 50:1500-1508
The CD20 cell surface antigen is expressed at high levels by over 90% of B-cell non-Hodgkin lymphomas (NHL) and is the target of the anti-CD20 monoclonal antibody rituximab. To provide more sensitive, tumor-specific PET imaging of NHL, we sought to d
Autor:
Sune Justesen, Muluneh Bekele Daba, Burkhard Fleckenstein, Inger Sandlie, Gøril Berntzen, Terje E. Michaelsen, Vigdis Lauvrak, Jan Terje Andersen, Søren Buus, Vania E. Kenanova
Publikováno v:
FEBS Journal. 275:4097-4110
The neonatal Fc receptor (FcRn) is a major histocompatibility complex class I-related molecule that regulates the half-life of IgG and albumin. In addition, FcRn directs the transport of IgG across both mucosal epithelium and placenta and also enhanc
Publikováno v:
Molecular Cancer Therapeutics. 5:1550-1558
Monoclonal antibodies (mAb) are being used at an increasing rate in the treatment of cancer, with current efforts focused on developing engineered antibodies that exhibit optimal biodistribution profiles for imaging and/or radioimmunotherapy. We rece
Autor:
Vania E. Kenanova, John E. Shively, Jeffrey Y.C. Wong, Paul J. Yazaki, Desiree Crow, Sanjiv S. Gambhir, Anna M. Wu, Andrew Raubitschek, Gobalakrishnan Sundaresan, Michael F. Press, Tove Olafsen, Anne-Line Anderson, Lin Li, Lawrence E. Williams
Publikováno v:
Cancer Research. 65:5907-5916
We have recently described the in vivo properties of an iodinated anti-p185HER2 engineered antibody fragment [minibody (scFv-CH3)2; 80 kDa], made from the internalizing 10H8 monoclonal antibody. Although the 10H8 minibody showed excellent binding to
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 29(3)
Single-step iodination is often performed in preference to use of a radiometal label for initial animal biodistributions. Yet loss of iodine occurs in vivo so that it is important to measure uptake (%ID/g) differences between radiolabels.Murine biodi
Autor:
Katelyn E. McCabe, Tove Olafsen, Mark D. Girgis, Vania E. Kenanova, Anna M. Wu, James S. Tomlinson
Publikováno v:
EJNMMI research, vol 1, iss 1
EJNMMI Research
EJNMMI Research
Background Sensitive antibody-based tumor targeting has the potential not only to image metastatic and micrometastatic disease, but also to be the basis of targeted therapy. The vast majority of pancreas cancers express carcinoembryonic antigen (CEA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218bede261bc38d1ec2e04c43e7120b4
https://escholarship.org/uc/item/0jf795t6
https://escholarship.org/uc/item/0jf795t6
Autor:
Anna M. Wu, Katelyn E. McCabe, Tove Olafsen, Vania E. Kenanova, Mark D. Girgis, James S. Tomlinson
Publikováno v:
The Journal of surgical research. 170(2)
Background Intact antibodies are poor imaging agents due to a long serum half-life (10–20 d) preventing adequate contrast between the tumor and surrounding blood. Smaller engineered antibody fragments overcome this problem by exhibiting shorter ser